JP2995652B2 - Method for producing tocol derivative-betaine composite powder and composite powder - Google Patents
Method for producing tocol derivative-betaine composite powder and composite powderInfo
- Publication number
- JP2995652B2 JP2995652B2 JP9095643A JP9564397A JP2995652B2 JP 2995652 B2 JP2995652 B2 JP 2995652B2 JP 9095643 A JP9095643 A JP 9095643A JP 9564397 A JP9564397 A JP 9564397A JP 2995652 B2 JP2995652 B2 JP 2995652B2
- Authority
- JP
- Japan
- Prior art keywords
- betaine
- acid
- derivative
- tocopherol
- composite powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960003237 betaine Drugs 0.000 title claims description 44
- 239000000843 powder Substances 0.000 title claims description 38
- DFUSDJMZWQVQSF-XLGIIRLISA-N (2r)-2-methyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol Chemical class OC1=CC=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 DFUSDJMZWQVQSF-XLGIIRLISA-N 0.000 title claims description 31
- 239000002131 composite material Substances 0.000 title claims description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 40
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 25
- 238000006243 chemical reaction Methods 0.000 claims description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- 229960000984 tocofersolan Drugs 0.000 claims description 16
- 239000002076 α-tocopherol Substances 0.000 claims description 16
- 235000019441 ethanol Nutrition 0.000 claims description 14
- 235000004835 α-tocopherol Nutrition 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 229940087168 alpha tocopherol Drugs 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 150000003611 tocopherol derivatives Chemical class 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 235000021313 oleic acid Nutrition 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- -1 polyglycerin Chemical compound 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 235000013772 propylene glycol Nutrition 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 description 11
- 229930003799 tocopherol Natural products 0.000 description 11
- 235000010384 tocopherol Nutrition 0.000 description 11
- 229960001295 tocopherol Drugs 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 1
- 229940023579 anhydrous betaine Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- QABCGOSYZHCPGN-UHFFFAOYSA-N chloro(dimethyl)silicon Chemical compound C[Si](C)Cl QABCGOSYZHCPGN-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003612 tocotrienol derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 1
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ビタミンE類を構
成するトコール誘導体とベタインとの複合体粉末の製造
方法及び同製造方法により製造された複合体粉末に関す
る。本発明の複合体粉末は医薬品、食品、化粧品等とし
て使用し得る。The present invention relates to a method for producing a composite powder of betaine and a tocol derivative constituting vitamin E, and to a composite powder produced by the production method. The composite powder of the present invention can be used as pharmaceuticals, foods, cosmetics and the like.
【0002】[0002]
【従来の技術】トコール誘導体は例えばトコフェロール
の如く油状であり、製剤化が容易でない。本願出願人中
の一社が所有する特許第1290022号にはトコール
誘導体を有機溶媒中でベタインと反応させて包接化して
成る化合物が示されている。この化合物はトコフェロー
ルなどのトコール誘導体をベタインで包接化して得られ
た結晶である。同特許に示されるようにこの包接化合物
は実施例によると、トコフェロールと無水ベタインとを
多量の有機溶媒(実施例ではエタノール)に溶解、加
温、1時間攪拌後、冷却晶析、晶析物を減圧下で濾過、
更に乾燥して製造されている。2. Description of the Related Art Tocol derivatives are oily, such as tocopherol, and are not easily formulated. Japanese Patent No. 1290022, which is owned by one of the present applicants, discloses a compound obtained by reacting a tocol derivative with betaine in an organic solvent to form an inclusion complex. This compound is a crystal obtained by inclusion of a tocol derivative such as tocopherol with betaine. As shown in the patent, according to the examples, this clathrate compound is prepared by dissolving tocopherol and anhydrous betaine in a large amount of an organic solvent (ethanol in the example), heating, stirring for 1 hour, cooling, and crystallizing. The substance was filtered under reduced pressure,
It is manufactured by drying.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、当該特
許による製造法には実用上多くの問題点がある。即ち、
溶媒はベタインとトコフェロールを完全に溶解する必要
があり、そのため使用量はベタインとトコフェロールの
合計量の3倍以上であり、安全性やコスト面で不利であ
る。特に、食品での使用を考慮してエタノールのように
溶媒を多量に使用すると、製品価格に占める溶媒のコス
トが大きい。また、大スケールでの実用的な製造を考え
た場合、収率は90%以下である。また、収率を上げる
ためにはろ液を濃縮したり、冷却して晶析させるなどエ
ネルギーの使用量が多大である。However, the manufacturing method according to the patent has many practical problems. That is,
It is necessary that the solvent completely dissolves betaine and tocopherol, so that the amount used is three times or more the total amount of betaine and tocopherol, which is disadvantageous in terms of safety and cost. In particular, when a large amount of a solvent such as ethanol is used in consideration of use in foods, the cost of the solvent in the product price is large. Further, in consideration of practical production on a large scale, the yield is 90% or less. In order to increase the yield, the amount of energy used is large, such as concentrating the filtrate or crystallizing it by cooling.
【0004】さらに、濾過したケーキ中の溶媒の含有量
が高く、これを乾燥するためのエネルギーも大きい。従
って簡単な工程でエネルギーの使用が少ないトコール誘
導体とベタインの複合体粉末の製造法の開発が実用的に
強く要望されている。本発明者らは、前記要望に応ずる
目的で研究を行った。その結果特定の物質がトコール誘
導体とベタインとの複合粉末生成反応を促進することを
確認した。例えば前述の特許第1290022号におい
てはその実施例に示されるように、α−トコフェロール
とベタインとを多量のエタノールに添加し、加温、攪拌
して溶解させ、次に複雑なプロセスにより複合体である
包接化合物が製造されている。即ち前記特許ではエタノ
ールは両者の溶媒として重要な機能を有していることが
示されている。一方本発明者らはα−トコフェロールと
ベタインに少量のエタノールを添加することにより、両
者はエタノールに溶解することなく、急速に反応して複
合体が生成すること、即ちエタノールは両者の反応促進
の作用を有することを確認した。換言すれば、反応促進
剤を少量存在させて両者を反応させることにより極めて
急速に両者の複合体が生成するのである。Further, the content of the solvent in the filtered cake is high, and the energy for drying the solvent is large. Therefore, there is a strong practical demand for the development of a method for producing a complex powder of a tocole derivative and betaine in a simple process and using less energy. The present inventors have conducted research for the purpose of responding to the above demand. As a result, it was confirmed that the specific substance accelerated the composite powder formation reaction between the tocol derivative and betaine. For example, in the above-mentioned Patent No. 1290022, as shown in the example, α-tocopherol and betaine are added to a large amount of ethanol, heated, stirred and dissolved, and then a complex is formed by a complex process. Certain clathrates have been produced. That is, the patent indicates that ethanol has an important function as both solvents. On the other hand, the present inventors added a small amount of ethanol to α-tocopherol and betaine, so that they did not dissolve in ethanol, but reacted rapidly to form a complex, that is, ethanol promoted the reaction of both. It was confirmed that it had an effect. In other words, by reacting the two in the presence of a small amount of a reaction accelerator, a complex of both is formed very rapidly.
【0005】[0005]
【課題を解決するための手段】即ち本発明はトコール誘
導体とベタインと特定の物質反応促進剤を混合すること
よりなるトコール誘導体−ベタイン複合体粉末の製造法
及び同方法により製造された複合体粉末に関する。That is, the present invention provides a method for producing a tocol derivative-betaine composite powder comprising mixing a tocol derivative, betaine and a specific substance reaction accelerator, and a composite powder produced by the method. About.
【0006】[0006]
【発明の実施の形態】本発明方法において用いられる特
定の反応促進剤とは、リン酸、クエン酸、炭酸、グリコ
ール酸、リンゴ酸、ポリ乳酸、オレイン酸、乳酸、グリ
セリン、エチルアルコール、プロピレングリコール、ポ
リグリセリン、乳酸セチル中の一種であり、後述する実
施例により極めて実用的であることが示されている。本
発明方法において、トコール誘導体とベタイン及び前述
の反応促進剤とを混合することにより、瞬時又は極めて
短時間でベタインの結晶が消失し、ほゞ白色の流動性の
あるトコール誘導体とベタインの複合体粉末を得ること
ができる。本発明方法において三成分の混合順序によ
り、粉末の生成状態に差がある。例えば、ベタインと反
応促進剤とを混合し、この混合物にトコール誘導体を添
加する方法によると、特に流動性の優れた粉末状の複合
体が得られることがわかった。DESCRIPTION OF THE PREFERRED EMBODIMENTS Specific reaction accelerators used in the method of the present invention include phosphoric acid, citric acid, carbonic acid, glycolic acid, malic acid, polylactic acid, oleic acid, lactic acid, glycerin, ethyl alcohol, propylene glycol , Polyglycerin, and cetyl lactate, which are shown to be extremely practical in the examples described below. In the method of the present invention, by mixing the tocol derivative with betaine and the above-described reaction accelerator, the betaine crystals disappear instantaneously or in an extremely short time, and a complex of almost white fluid tocol derivative and betaine is obtained. A powder can be obtained. In the method of the present invention, there is a difference in the state of powder production depending on the mixing order of the three components. For example, according to the method of mixing betaine and a reaction accelerator and adding a tocol derivative to the mixture, it was found that a powdery composite having particularly excellent fluidity was obtained.
【0007】尚、三者を同時に混合しても、又トコール
誘導体と反応促進剤とを混合し、次にベタインを添加し
ても特に支障は生じない。又、更に必要により前記三成
分に有機溶媒を少量、例えば三成分の合計量に対して重
量%で2〜10添加すると例えば次のような効果があ
る。即ち得られた粉末状の複合体の微粒化度、白色度等
が向上する。[0007] Even if the three are mixed simultaneously, or if the tocole derivative and the reaction accelerator are mixed and then betaine is added, no particular problem occurs. Further, if necessary, a small amount of an organic solvent may be added to the three components, for example, 2 to 10% by weight based on the total amount of the three components. That is, the degree of atomization, whiteness, and the like of the obtained powdery composite are improved.
【0008】[0008]
【0009】[0009]
【0010】[0010]
【0011】本発明のトコール誘導体としては実用上ト
コフェロール誘導体が好ましい。トコフェロール誘導体
の具体例としては、d−α−トコフェロール、d−β−
トコフェロール、d−γ−トコフェロール、d−δ−ト
コフェロール、d,1−α−トコフェロール及びこれら
の混合物を例示することができる。そして特に好ましい
のはd−α−トコフェロール、d,1−α−トコフェロ
ールである。As the tocol derivative of the present invention, a tocopherol derivative is practically preferable. Specific examples of tocopherol derivatives include d-α-tocopherol, d-β-
Examples include tocopherol, d-γ-tocopherol, d-δ-tocopherol, d, 1-α-tocopherol and mixtures thereof. Particularly preferred are d-α-tocopherol and d, 1-α-tocopherol.
【0012】トコール誘導体としてはトコトリエノール
誘導体も使用可能であり、d−α−トコトリエノール,
d−β−トコトリエノール、d−γ−トコトリエノール
等を例示することができる。本発明に使用する反応促進
剤の添加量としては特に制限はないが、作業性、粉末の
状態などを考慮するとトコール誘導体とベタインの総重
量に対して100%以下が望ましい。As the tocol derivative, a tocotrienol derivative can also be used, and d-α-tocotrienol,
Examples thereof include d-β-tocotrienol and d-γ-tocotrienol. The amount of the reaction accelerator used in the present invention is not particularly limited, but is preferably 100% or less based on the total weight of the tocol derivative and betaine in consideration of workability, powder state, and the like.
【0013】更に好ましくはトコール誘導体とベタイン
の総重量に対して20%以下である。反応促進剤が多過
ぎると複合体中の有効成分が少なく、得られた複合体粉
末の性質が低下し、また反応促進剤が液体の場合、混合
物がべとつくので好ましくない。また余り少量では効果
がなくなるので少なくともトコール誘導体とベタインの
合計量の0.5重量%であることが望ましい。又、反応
促進剤は実質的に触媒として作用していると考えられ
る。[0013] More preferably, the content is 20% or less based on the total weight of the tocol derivative and betaine. If the amount of the reaction accelerator is too large, the amount of the active ingredient in the composite is small, and the properties of the obtained composite powder are deteriorated. Since the effect is lost if the amount is too small, it is preferable that the amount is at least 0.5% by weight of the total amount of the tocol derivative and betaine. Further, it is considered that the reaction accelerator substantially functions as a catalyst.
【0014】トコール誘導体とベタインとの混合比は重
量で、トコール誘導体10に対してベタイン10〜0.
5の範囲とすることが必要である。ベタインが多過ぎる
と複合体単位当りのビタミンEとしての効果が少なく、
ベタインが少な過ぎると粉末の生成が困難となる。The mixing ratio of the tocol derivative and betaine is by weight.
5 is required. If there is too much betaine, the effect as vitamin E per complex unit is small,
If the amount of betaine is too small, it becomes difficult to produce a powder.
【0015】トコール誘導体の重量に対して10%程度
のベタイン量でも非常にきれいな白色粉末が得られるが
(トコール誘導体の含有量は90重量%)、トコール誘
導体:ベタイン:反応促進剤の最適重量比は25:8:
1である。本発明の複合体粉末は包接化合物であると考
えられる。本発明の複合体は安定的に長期保存が可能で
ある。Although a very clean white powder can be obtained even when the amount of betaine is about 10% based on the weight of the tocol derivative (the content of the tocol derivative is 90% by weight), the optimum weight ratio of the tocol derivative: betaine: reaction accelerator is obtained. Is 25: 8:
It is one. The composite powder of the present invention is considered to be an inclusion compound. The complex of the present invention can be stably stored for a long period of time.
【0016】[0016]
【実施例】以下、実施例を挙げて本発明を具体的に説明
すると、本発明はこれらに限定されるものではない。EXAMPLES Hereinafter, the present invention will be described specifically with reference to Examples, but the present invention is not limited to these.
【0017】実施例 1 d−α−トコフェロール250gとベタイン68gを5
00リットルのステンレスビーカーに秤量し、攪拌機に
て良く混合した。攪拌しながらこの混合物にクエン酸2
7gを少量ずつ添加した。クエン酸を全て添加した時点
で、水を5g添加し10分間混合した。混合を終了した
時点で、やや湿った、やや黄色味を帯びた流動性のある
粉末が得られた。この粉末を室温で減圧乾燥し白色のト
コフェロール−ベタイン複合体粉末331gを得た。収
率は約96%であった。EXAMPLE 1 250 g of d-α-tocopherol and 68 g of betaine were added to 5
It was weighed in a 00 liter stainless beaker and mixed well with a stirrer. While stirring, add 2 citric acid
7 g were added in small portions. When all the citric acid was added, 5 g of water was added and mixed for 10 minutes. At the end of the mixing, a slightly moist, slightly yellowish, free-flowing powder was obtained. This powder was dried at room temperature under reduced pressure to obtain 331 g of a white tocopherol-betaine complex powder. The yield was about 96%.
【0018】[0018]
【0019】実施例 2 ベタイン60gとクエン酸の10%アセトン溶液30g
を500mlのガラス製ビーカーに仕込み、良く混合し
た。攪拌しながらこれにd−α−トコフェロールを12
0g添加した。反応は瞬間的に終了しさらさらの非常に
細かい粉末177gを得た。この粉末はトコフェロール
とベタインの複合体であり、収率は約98%であり、ト
コフェロールの含量は64%であった。Example 2 60 g of betaine and 30 g of a 10% acetone solution of citric acid
Was charged into a 500 ml glass beaker and mixed well. While stirring, add 12 g of α-tocopherol to this.
0 g was added. The reaction was completed instantaneously, and 177 g of a very fine and smooth powder was obtained. This powder was a complex of tocopherol and betaine, the yield was about 98%, and the content of tocopherol was 64%.
【0020】実施例 3 d−α−トコフェロール100gとベタイン100gを
500mlガラス製ビーカーに仕込み、攪拌しながらこ
れにグリセリン24gを添加した。反応はややゆっくり
と進み、湿った粉末220gを得た。収率は約98%で
あった。Example 3 100 g of d-α-tocopherol and 100 g of betaine were charged into a 500 ml glass beaker, and 24 g of glycerin was added thereto with stirring. The reaction proceeded slightly more slowly, yielding 220 g of wet powder. The yield was about 98%.
【0021】実施例 4 d−α−トコフェロール100gとベタイン100gを
500mlガラス製ビーカーに仕込み、攪拌しながらこ
れにエチルアルコール25gを添加した。反応はややゆ
っくりと進み、湿った粉末220gを得た。収率は約9
9%であった。Example 4 100 g of d-α-tocopherol and 100 g of betaine were charged into a 500 ml glass beaker, and 25 g of ethyl alcohol was added thereto with stirring. The reaction proceeded slightly more slowly, yielding 220 g of wet powder. The yield is about 9
9%.
【0022】実施例 5 d−α−トコフェロール1kgと乳酸の10%アセトン
溶液200gを混練機に仕込み、混合しながら1kgの
ベタインを徐々に添加した。トコフェロールを添加し始
めると白色の粉末が生成し始め、添加終了後には流動性
の良い白色の粉末が得られた。攪拌を約1時間続けたと
ころ、アセトンがほゞ完全に蒸散し、さらさらの白色粉
末が得られた。この白色粉末はトコフェロールとベタイ
ンの複合体粉末であり、収率は約99.5%であった。Example 5 1 kg of d-α-tocopherol and 200 g of a 10% acetone solution of lactic acid were charged into a kneader, and 1 kg of betaine was gradually added while mixing. When the addition of tocopherol was started, a white powder began to be formed, and after the addition, a white powder having good fluidity was obtained. When stirring was continued for about 1 hour, acetone was almost completely evaporated, and a smooth white powder was obtained. This white powder was a composite powder of tocopherol and betaine, and the yield was about 99.5%.
【0023】実施例 6 予め、d−α−トコフェロールとベタインの重量比で
1:1の混合物を調製した。この混合物に表1に示す各
種の反応促進剤を添加し、複合体粉末が生成する時間と
粉末状態を観察した。混合物100gに対して反応促進
剤の添加量は3gであった。表1中、反応時間が遅いは
約30秒、早いは2〜3秒を、やや遅いは前記両者の中
間を示す。Example 6 A mixture of d-α-tocopherol and betaine at a weight ratio of 1: 1 was previously prepared. Various reaction accelerators shown in Table 1 were added to this mixture, and the time and powder state of the composite powder were observed. The amount of the reaction accelerator added was 3 g per 100 g of the mixture. In Table 1, the reaction time is slow for about 30 seconds, fast for 2-3 seconds, and slightly slow for intermediates between the two.
【0024】[0024]
【表1】 [Table 1]
【0025】実験例 本発明の方法により製造された複合体粉末を用いて安定
性試験を行った。その結果を表2に示す。Experimental Example A stability test was conducted using the composite powder produced by the method of the present invention. Table 2 shows the results.
【表2】 [Table 2]
【0026】試験に用いた粉末の組成、補正後の安定
値、定量法、定量法に用いた水素炎ガスクロマトグラフ
ィの条件を次に示す。尚、乾燥減量は減圧50℃、2時
間の条件による数値である。 粉末の組成 トコフェロール 70g ベタイン 35g 乳酸 31.5g 補正後の定量値=(安定値)/(100−乾燥減量) 定量法: 標準d−α−トコフェロール0.2471g
を精密に計量し、100mlのエタノールに溶解する。
一方、試料0.6429gを精密に計量し、100ml
のエタノールに溶解する。乳糖がエタノールに不溶なの
で、濾過して定量用試料とし、3μL水素炎ガスクロマ
トグラフィに注入し、標準との面積比でd−α−トコフ
ェロールの含量を算出する。 水素炎ガスクロマトグラフィの条件 カラム :内径3.2mm、長さ1.1mmの
ガラスカラムに、シリコンGE SE−30,10%を
担体クロモソルブ W AW DMCS 60〜80m
eshes充填する。 カラム温度 :260℃、注入温度、280℃ キャリアーガス :N2 ガス 検出器 :FID 注入量 :3μLThe composition of the powder used in the test, the stable value after correction, the quantification method, and the conditions of the flame gas chromatography used in the quantification method are shown below. The loss on drying is a numerical value obtained under the conditions of reduced pressure of 50 ° C. and 2 hours. Powder composition Tocopherol 70 g Betain 35 g Lactic acid 31.5 g Quantitative value after correction = (stable value) / (100-loss on drying) Quantitation method: 0.2471 g of standard d-α-tocopherol
Is precisely weighed and dissolved in 100 ml of ethanol.
On the other hand, 0.6429 g of the sample was precisely weighed and 100 ml
Dissolve in ethanol. Since lactose is insoluble in ethanol, it is filtered to obtain a sample for quantification, injected into 3 μL hydrogen flame gas chromatography, and the content of d-α-tocopherol is calculated by the area ratio with the standard. Conditions for hydrogen flame gas chromatography Column: Silicon GE SE-30, 10% was applied to a glass column having an inner diameter of 3.2 mm and a length of 1.1 mm, and a carrier chromosolve WAW DMCS 60 to 80 m.
eshes filling. Column temperature: 260 ° C, injection temperature, 280 ° C Carrier gas: N 2 gas Detector: FID Injection amount: 3 μL
【0027】[0027]
【発明の効果】本発明のトコール誘導体−ベタイン複合
体粉末の製造法は有機溶媒を使用する必要がなく、安全
性と生産コストの点で有利である。濾過工程がないので
製品のロスが少なく、100%に近い収率を達成でき
る。また、反応促進剤として例えばクエン酸、炭酸等の
固体状の反応促進剤を使用の場合、乾燥工程が不要であ
り、エネルギーの使用が非常に少ない。更に複合体が液
状の場合は、カプセルに封入するが、本発明方法により
製造される複合体は錠剤や顆粒として用いられる。更に
本発明の複合体は実験例に示すように長期安定して保存
できる。The method of the present invention for producing a tocol derivative-betaine composite powder does not require the use of an organic solvent, and is advantageous in terms of safety and production cost. Since there is no filtration step, product loss is small, and a yield close to 100% can be achieved. Further, when a solid reaction accelerator such as citric acid or carbonic acid is used as the reaction accelerator, a drying step is not required, and the energy consumption is very small. Furthermore, when the complex is liquid, it is encapsulated in a capsule, but the complex produced by the method of the present invention is used as tablets or granules. Further, the complex of the present invention can be stably stored for a long period of time as shown in the experimental examples.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 9/14 A61K 47/10 47/10 47/12 47/12 47/14 47/14 47/18 47/18 47/24 47/24 47/34 47/34 9/14 (58)調査した分野(Int.Cl.6,DB名) A61K 31/355 A23L 1/302 A61K 7/00 A61K 7/48 A61K 9/14 A61K 47/10 A61K 47/12 A61K 47/14 A61K 47/18 A61K 47/24 A61K 47/34 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 9/14 A61K 47/10 47/10 47/12 47/12 47/14 47/14 47/18 47/18 47/24 47/24 47/34 47/34 9/14 (58) Fields investigated (Int.Cl. 6 , DB name) A61K 31/355 A23L 1/302 A61K 7/00 A61K 7/48 A61K 9/14 A61K 47 / 10 A61K 47/12 A61K 47/14 A61K 47/18 A61K 47/24 A61K 47/34
Claims (7)
としてのリン酸、クエン酸、炭酸、グリコール酸、リン
ゴ酸、ポリ乳酸、オレイン酸、乳酸、グリセリン、エチ
ルアルコール、プロピレングリコール、ポリグリセリ
ン、乳酸セチル中の一種とを混合することよりなるトコ
ール誘導体−ベタイン複合体粉末の製造法。1. Tocol derivative, betaine and phosphoric acid, citric acid, carbonic acid, glycolic acid, malic acid, polylactic acid, oleic acid, lactic acid, glycerin, ethyl alcohol, propylene glycol, polyglycerin, cetyl lactate as a reaction accelerator A method for producing a tocol derivative-betaine complex powder, comprising mixing one of the above.
の混合は先ずベタインと反応促進剤とを混合し、得られ
た混合物にトコール誘導体を添加することよりなる請求
項1の複合体粉末の製造法。2. The method for producing a composite powder according to claim 1, wherein the mixing of the tocol derivative, betaine, and the reaction accelerator comprises first mixing betaine and the reaction accelerator, and adding the tocol derivative to the obtained mixture. .
トコール誘導体10に対してベタイン10〜0.5の範
囲である請求項1の複合体粉末の製造法。3. The method according to claim 1, wherein the weight ratio of the tocol derivative to betaine is in the range of 10 to 0.5 betaine to 10 tocol derivative.
である請求項1の複合体粉末の製造法。4. The method according to claim 1, wherein the tocol derivative is a tocopherol derivative.
ェロール、d,1−α−トコフェロール中の少なくとも
一種である請求項4の複合体粉末の製造法。5. The method according to claim 4, wherein the tocopherol derivative is at least one of d-α-tocopherol and d, 1-α-tocopherol.
としてのリン酸、クエン酸、炭酸、グリコール酸、リン
ゴ酸、ポリ乳酸、オレイン酸、乳酸、グリセリン、エチ
ルアルコール、プロピレングリコール、ポリグリセリ
ン、乳酸セチル中の一種とを混合して得られた複合体粉
末。6. Tocol derivative, betaine and phosphoric acid, citric acid, carbonic acid, glycolic acid, malic acid, polylactic acid, oleic acid, lactic acid, glycerin, ethyl alcohol, propylene glycol, polyglycerin, cetyl lactate as a reaction accelerator Composite powder obtained by mixing with one of the above.
トコール誘導体10に対してベタイン10〜0.5の範
囲である請求項6の複合体粉末。7. The composite powder according to claim 6, wherein the weight ratio of the tocol derivative to betaine is in the range of 10 to 0.5 betaine to 10 tocol derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9095643A JP2995652B2 (en) | 1997-04-14 | 1997-04-14 | Method for producing tocol derivative-betaine composite powder and composite powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9095643A JP2995652B2 (en) | 1997-04-14 | 1997-04-14 | Method for producing tocol derivative-betaine composite powder and composite powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10287564A JPH10287564A (en) | 1998-10-27 |
| JP2995652B2 true JP2995652B2 (en) | 1999-12-27 |
Family
ID=14143200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9095643A Expired - Lifetime JP2995652B2 (en) | 1997-04-14 | 1997-04-14 | Method for producing tocol derivative-betaine composite powder and composite powder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2995652B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107267337A (en) * | 2016-08-08 | 2017-10-20 | 山东祥维斯生物科技股份有限公司 | The preparation method of application and alcoholic beverage of the glycine betaine in alcoholic beverage is prepared |
| CN113100490A (en) * | 2021-05-21 | 2021-07-13 | 张家港外星人新材料科技有限公司 | Alkaloid and phenol reaction composition, atomized liquid, atomized bomb and electronic atomizer |
| CN118476613A (en) * | 2024-05-07 | 2024-08-13 | 共晶健康产业(浙江)有限责任公司 | Solvent-free preparation method of alpha-tocopherol and betaine compound |
-
1997
- 1997-04-14 JP JP9095643A patent/JP2995652B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10287564A (en) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI82189B (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN STABIL MODIFIKATION AV TORASEMID. | |
| EP2918585A1 (en) | Pyrroloquinoline quinone disodium salt crystal | |
| CN111423444B (en) | Resveratrol-temozolomide cocrystal and preparation method and application thereof | |
| HU229087B1 (en) | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent | |
| CN101633624B (en) | Preparation method of improved di-lysine-aspirin | |
| JP2995652B2 (en) | Method for producing tocol derivative-betaine composite powder and composite powder | |
| EP2503990B1 (en) | Process for the preparation of gadobenate dimeglumine complex in a solid form | |
| CA2225022C (en) | New polymorphous form of doxazosine mesylate (form iii) | |
| FR2598415A1 (en) | Process for the preparation of a standard mixture of mono-O-( beta -hydroxyethyl)diosmins and of di-O-( beta -hydroxyethyl)diosmin | |
| CZ163296A3 (en) | Iopamidol purification and crystallization process | |
| EP4367124B1 (en) | Method for preparing diosmin and flavonoid fraction | |
| CN108929227B (en) | Method for synthesizing aromatic benzyl ester by oxidizing and self-coupling benzyl halide | |
| JPS59104311A (en) | Light shielding agent | |
| CN104135997B (en) | Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin | |
| JP5126942B2 (en) | 5,7-dideoxyepigallocatechin gallate, process for producing the same, and anti-influenza virus agent | |
| JPS5934710B2 (en) | Method for producing a molecular compound of allantoin and ornithine | |
| CN120554206B (en) | A ketone containing a phenolic functional group, its preparation method, and its application in the synthesis of dihydroquercetin. | |
| US2891068A (en) | Quaternary ammonium acyl derivatives of vitamin a aldehyde hydrazones | |
| US20080091006A1 (en) | Nitrate ester cyclodextrin complexes | |
| JPS5811959B2 (en) | Cycloartenol succinic acid ester alkali metal salt | |
| JP2002506454A (en) | Nifedipine manufacturing method | |
| JP3337251B2 (en) | Method for producing quinoveon | |
| JPH11246548A (en) | Method for producing solid vitamin E | |
| JPH09216854A (en) | Production of 3-chloro-3'-nitro-4'-methoxybenzophenone | |
| KR20170066998A (en) | Retinoid Compounds containing dopamine and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081029 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091029 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101029 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101029 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111029 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121029 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131029 Year of fee payment: 14 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |